Pan-cancer and single-cell analysis reveal the prognostic value and immune response of NQO1

Background: Overexpression of the NAD(P)H: Quinone Oxidoreductase 1 (NQOI) gene has been linked with tumor progression, aggressiveness, drug resistance, and poor patient prognosis. Most research has described the biological function of the NQO1 in certain types and limited samples, but a comprehensi...

Full description

Bibliographic Details
Main Authors: Liping Shen, Shan Jiang, Yu Yang, Hongli Yang, Yanchun Fang, Meng Tang, Rangteng Zhu, Jiaqin Xu, Hantao Jiang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-07-01
Series:Frontiers in Cell and Developmental Biology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcell.2023.1174535/full
_version_ 1797768709105778688
author Liping Shen
Shan Jiang
Yu Yang
Hongli Yang
Yanchun Fang
Meng Tang
Rangteng Zhu
Jiaqin Xu
Hantao Jiang
author_facet Liping Shen
Shan Jiang
Yu Yang
Hongli Yang
Yanchun Fang
Meng Tang
Rangteng Zhu
Jiaqin Xu
Hantao Jiang
author_sort Liping Shen
collection DOAJ
description Background: Overexpression of the NAD(P)H: Quinone Oxidoreductase 1 (NQOI) gene has been linked with tumor progression, aggressiveness, drug resistance, and poor patient prognosis. Most research has described the biological function of the NQO1 in certain types and limited samples, but a comprehensive understanding of the NQO1’s function and clinical importance at the pan-cancer level is scarce. More research is needed to understand the role of NQO1 in tumor infiltration, and immune checkpoint inhibitors in various cancers are needed.Methods: The NQO1 expression data for 33 types of pan-cancer and their association with the prognosis, pathologic stage, gender, immune cell infiltration, the tumor mutation burden, microsatellite instability, immune checkpoints, enrichment pathways, and the half-maximal inhibitory concentration (IC50) were downloaded from public databases.Results: Our findings indicate that the NQO1 gene was significantly upregulated in most cancer types. The Cox regression analysis showed that overexpression of the NQO1 gene was related to poor OS in Glioma, uveal melanoma, head and neck squamous cell carcinoma, kidney renal papillary cell carcinoma, and adrenocortical carcinoma. NQO1 mRNA expression positively correlated with infiltrating immune cells and checkpoint molecule levels. The single-cell analysis revealed a potential relationship between the NQO1 mRNA expression levels and the infiltration of immune cells and stromal cells in bladder urothelial carcinoma, invasive breast carcinoma, and colorectal cancer. Conversely, a negative association was noted between various drugs (17-AAG, Lapatinib, Trametinib, PD-0325901) and the NQO1 mRNA expression levels.Conclusion: NQO1 expression was significantly associated with prognosis, immune infiltrates, and drug resistance in multiple cancer types. The inhibition of the NQO1-dependent signaling pathways may provide a promising strategy for developing new cancer-targeted therapies.
first_indexed 2024-03-12T20:57:11Z
format Article
id doaj.art-914c78f61ccb45cd926482b2031e5985
institution Directory Open Access Journal
issn 2296-634X
language English
last_indexed 2024-03-12T20:57:11Z
publishDate 2023-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cell and Developmental Biology
spelling doaj.art-914c78f61ccb45cd926482b2031e59852023-07-31T14:39:41ZengFrontiers Media S.A.Frontiers in Cell and Developmental Biology2296-634X2023-07-011110.3389/fcell.2023.11745351174535Pan-cancer and single-cell analysis reveal the prognostic value and immune response of NQO1Liping Shen0Shan Jiang1Yu Yang2Hongli Yang3Yanchun Fang4Meng Tang5Rangteng Zhu6Jiaqin Xu7Hantao Jiang8Department of Clinical Laboratory, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical, Taizhou, Zhejiang, ChinaDepartment of Radiology, Jining No. 1 People’s Hospital, Jining, Shandong, ChinaDepartment of Orthopedics, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical, Taizhou, Zhejiang, ChinaDepartment of Pathology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, ChinaDepartment of Ultrasonography, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical, Taizhou, Zhejiang, ChinaDepartment of Ultrasonography, Jining No. 1 People’s Hospital, Jining, Shandong, ChinaDepartment of Orthopedics, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical, Taizhou, Zhejiang, ChinaDepartment of Clinical Laboratory, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical, Taizhou, Zhejiang, ChinaDepartment of Orthopedics, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical, Taizhou, Zhejiang, ChinaBackground: Overexpression of the NAD(P)H: Quinone Oxidoreductase 1 (NQOI) gene has been linked with tumor progression, aggressiveness, drug resistance, and poor patient prognosis. Most research has described the biological function of the NQO1 in certain types and limited samples, but a comprehensive understanding of the NQO1’s function and clinical importance at the pan-cancer level is scarce. More research is needed to understand the role of NQO1 in tumor infiltration, and immune checkpoint inhibitors in various cancers are needed.Methods: The NQO1 expression data for 33 types of pan-cancer and their association with the prognosis, pathologic stage, gender, immune cell infiltration, the tumor mutation burden, microsatellite instability, immune checkpoints, enrichment pathways, and the half-maximal inhibitory concentration (IC50) were downloaded from public databases.Results: Our findings indicate that the NQO1 gene was significantly upregulated in most cancer types. The Cox regression analysis showed that overexpression of the NQO1 gene was related to poor OS in Glioma, uveal melanoma, head and neck squamous cell carcinoma, kidney renal papillary cell carcinoma, and adrenocortical carcinoma. NQO1 mRNA expression positively correlated with infiltrating immune cells and checkpoint molecule levels. The single-cell analysis revealed a potential relationship between the NQO1 mRNA expression levels and the infiltration of immune cells and stromal cells in bladder urothelial carcinoma, invasive breast carcinoma, and colorectal cancer. Conversely, a negative association was noted between various drugs (17-AAG, Lapatinib, Trametinib, PD-0325901) and the NQO1 mRNA expression levels.Conclusion: NQO1 expression was significantly associated with prognosis, immune infiltrates, and drug resistance in multiple cancer types. The inhibition of the NQO1-dependent signaling pathways may provide a promising strategy for developing new cancer-targeted therapies.https://www.frontiersin.org/articles/10.3389/fcell.2023.1174535/fullNQO1pan-cancerimmuneprognosistherapy
spellingShingle Liping Shen
Shan Jiang
Yu Yang
Hongli Yang
Yanchun Fang
Meng Tang
Rangteng Zhu
Jiaqin Xu
Hantao Jiang
Pan-cancer and single-cell analysis reveal the prognostic value and immune response of NQO1
Frontiers in Cell and Developmental Biology
NQO1
pan-cancer
immune
prognosis
therapy
title Pan-cancer and single-cell analysis reveal the prognostic value and immune response of NQO1
title_full Pan-cancer and single-cell analysis reveal the prognostic value and immune response of NQO1
title_fullStr Pan-cancer and single-cell analysis reveal the prognostic value and immune response of NQO1
title_full_unstemmed Pan-cancer and single-cell analysis reveal the prognostic value and immune response of NQO1
title_short Pan-cancer and single-cell analysis reveal the prognostic value and immune response of NQO1
title_sort pan cancer and single cell analysis reveal the prognostic value and immune response of nqo1
topic NQO1
pan-cancer
immune
prognosis
therapy
url https://www.frontiersin.org/articles/10.3389/fcell.2023.1174535/full
work_keys_str_mv AT lipingshen pancancerandsinglecellanalysisrevealtheprognosticvalueandimmuneresponseofnqo1
AT shanjiang pancancerandsinglecellanalysisrevealtheprognosticvalueandimmuneresponseofnqo1
AT yuyang pancancerandsinglecellanalysisrevealtheprognosticvalueandimmuneresponseofnqo1
AT hongliyang pancancerandsinglecellanalysisrevealtheprognosticvalueandimmuneresponseofnqo1
AT yanchunfang pancancerandsinglecellanalysisrevealtheprognosticvalueandimmuneresponseofnqo1
AT mengtang pancancerandsinglecellanalysisrevealtheprognosticvalueandimmuneresponseofnqo1
AT rangtengzhu pancancerandsinglecellanalysisrevealtheprognosticvalueandimmuneresponseofnqo1
AT jiaqinxu pancancerandsinglecellanalysisrevealtheprognosticvalueandimmuneresponseofnqo1
AT hantaojiang pancancerandsinglecellanalysisrevealtheprognosticvalueandimmuneresponseofnqo1